189 related articles for article (PubMed ID: 34958114)
1. Methylation and mutation of the inhibin‑α gene in human melanoma cells and regulation of PTEN expression and AKT/PI3K signaling by a demethylating agent.
Ko H; Ahn HJ; Kim YI
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34958114
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional silencing of the inhibin-α gene in human gastric carcinoma cells.
Kim YI; Shim J; Kim BH; Lee SJ; Lee HK; Cho C; Cho BN
Int J Oncol; 2012 Aug; 41(2):690-700. PubMed ID: 22581369
[TBL] [Abstract][Full Text] [Related]
3. Interplay between PREX2 mutations and the PI3K pathway and its effect on epigenetic regulation of gene expression in NRAS-mutant melanoma.
Lissanu Deribe Y
Small GTPases; 2016 Jul; 7(3):178-85. PubMed ID: 27111337
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of DJ-1 expression in melanoma regulates PTEN/AKT pathway for cell survival and migration.
Lee YJ; Kim WI; Park TH; Bae JH; Nam HS; Cho SW; Choi YJ; Lee SH; Cho MK
Arch Dermatol Res; 2021 Sep; 313(7):583-591. PubMed ID: 32959108
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anti-malignant melanoma activity of Alocasia cucullata via modulation of the phosphatase and tensin homolog/phosphoinositide 3-kinase/AKT pathway.
Fang M; Zhu D; Luo C; Li C; Zhu C; Ou J; Li H; Zhou Y; Huo C; Liu W; Peng J; Peng Q; Mo Z
J Ethnopharmacol; 2018 Mar; 213():359-365. PubMed ID: 29180042
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
7. Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.
Foster JS; Fish LM; Phipps JE; Bruker CT; Lewis JM; Bell JL; Solomon A; Kestler DP
BMC Cancer; 2013 May; 13():227. PubMed ID: 23648148
[TBL] [Abstract][Full Text] [Related]
8. Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma.
Lissanu Deribe Y; Shi Y; Rai K; Nezi L; Amin SB; Wu CC; Akdemir KC; Mahdavi M; Peng Q; Chang QE; Hornigold K; Arold ST; Welch HC; Garraway LA; Chin L
Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1296-305. PubMed ID: 26884185
[TBL] [Abstract][Full Text] [Related]
9. Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma.
Huang KH; Huang SF; Chen IH; Liao CT; Wang HM; Hsieh LL
Clin Cancer Res; 2009 Jun; 15(12):4174-80. PubMed ID: 19509163
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3'-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN.
Hartmann W; Digon-Söntgerath B; Koch A; Waha A; Endl E; Dani I; Denkhaus D; Goodyer CG; Sörensen N; Wiestler OD; Pietsch T
Clin Cancer Res; 2006 May; 12(10):3019-27. PubMed ID: 16707597
[TBL] [Abstract][Full Text] [Related]
11. Inhibin-α gene mutations and mRNA levels in human lymphoid and myeloid leukemia cells.
Kim YI; Park SW; Kwon HS; Yang HS; Cho SY; Kim YJ; Lee HJ
Int J Oncol; 2017 Apr; 50(4):1403-1412. PubMed ID: 28260095
[TBL] [Abstract][Full Text] [Related]
12. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome.
Mueller S; Phillips J; Onar-Thomas A; Romero E; Zheng S; Wiencke JK; McBride SM; Cowdrey C; Prados MD; Weiss WA; Berger MS; Gupta N; Haas-Kogan DA
Neuro Oncol; 2012 Sep; 14(9):1146-52. PubMed ID: 22753230
[TBL] [Abstract][Full Text] [Related]
13. Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation.
Peterziel H; Müller J; Danner A; Barbus S; Liu HK; Radlwimmer B; Pietsch T; Lichter P; Schütz G; Hess J; Angel P
Neuro Oncol; 2012 Apr; 14(4):426-39. PubMed ID: 22394497
[TBL] [Abstract][Full Text] [Related]
14. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors.
Hou P; Ji M; Xing M
Cancer; 2008 Nov; 113(9):2440-7. PubMed ID: 18831514
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study.
Govatati S; Kodati VL; Deenadayal M; Chakravarty B; Shivaji S; Bhanoori M
Hum Reprod; 2014 Feb; 29(2):324-36. PubMed ID: 24154570
[TBL] [Abstract][Full Text] [Related]
16. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.
Ma J; Sun X; Wang Y; Chen B; Qian L; Wang Y
Cell Commun Signal; 2019 Sep; 17(1):119. PubMed ID: 31500630
[TBL] [Abstract][Full Text] [Related]
18. PTEN Methylation Dependent Sinonasal Mucosal Melanoma.
Lee SH; Roh MR; Kang B; Park KH; Kim SH; Lee SE; Rha SY
Cancer Res Treat; 2016 Apr; 48(2):853-8. PubMed ID: 25797573
[TBL] [Abstract][Full Text] [Related]
19. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
